Propanc Biopharma, Inc. (PPCB) — Net Income

Annual figures by fiscal year, from SEC filings.

2009: -$443.8K2010: -$842.5K2011: -$2.15M2012: -$11.43M2013: -$1.44M2014: -$829.6K2015: -$3.41M2016: -$9.41M2017: -$7.87M2018: -$7.04M2019: -$5.76M2020: -$4.74M2021: -$2.03M2022: -$2.66M2023: -$2.66M2024: -$1.82M2025: -$58.92M-$58.92M
2009Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$58.92M-3136.6%
2024-$1.82M+31.6%
2023-$2.66M-0.1%
2022-$2.66M-31.2%
2021-$2.03M+57.3%
2020-$4.74M+17.7%
2019-$5.76M+18.2%
2018-$7.04M+10.5%
2017-$7.87M+16.4%
2016-$9.41M-175.7%
2015-$3.41M-311.4%
2014-$829.6K+42.5%
2013-$1.44M+87.4%
2012-$11.43M-431.3%
2011-$2.15M-155.4%
2010-$842.5K-89.8%
2009-$443.8K